BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+46.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.07B
AUM Growth
+$7.07B
(+37%)
Cap. Flow
+$60.6M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
231
New
17
Increased
84
Reduced
52
Closed
23
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$38.5M |
| 2 |
Generation Bio
GBIO
|
$30.2M |
| 3 |
Stryker
SYK
|
$27.2M |
| 4 |
Insulet
PODD
|
$25.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$23.9M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$84.3M |
| 2 |
Moderna
MRNA
|
$38.9M |
| 3 |
Illumina
ILMN
|
$38.1M |
| 4 |
Intuitive Surgical
ISRG
|
$36.5M |
| 5 |
MacroGenics
MGNX
|
$31.2M |
Sector Composition
| 1 | Healthcare | 96.05% |
| 2 | Industrials | 0.58% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.29% |
| 5 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Illumina
ILMN
$15.8B
| $35.6M | 0.5% |
96,047
-102,941
| -52% | -$38.1M |
|
52
Sangamo Therapeutics
SGMO
$157M
| $34.5M | 0.49% |
3,850,000
| – | – |
|
53
Voyager Therapeutics
VYGR
$186M
| $34.2M | 0.48% |
2,712,083
-12,000
| -0.4% | -$151K |
|
|
ICPT
54
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $33.8M | 0.48% |
704,976
-4,000
| -0.6% | -$192K |
|
55
HCA Healthcare
HCA
$94.5B
| $33.3M | 0.47% |
343,166
+70,200
| +26% | +$6.81M |
|
56
Jazz Pharmaceuticals
JAZZ
$7.75B
| $32.1M | 0.45% |
291,136
-80,201
| -22% | -$8.85M |
|
57
Hologic
HOLX
$14.9B
| $30.3M | 0.43% |
531,089
-36,690
| -6% | -$2.09M |
|
|
58
Generation Bio
GBIO
$40.4M
| $30.2M | 0.43% |
+1,440,000
| New | +$30.2M |
|
59
Molina Healthcare
MOH
$9.8B
| $29.3M | 0.41% |
164,572
+36,366
| +28% | +$6.47M |
|
60
Teladoc Health
TDOC
$1.37B
| $28.9M | 0.41% |
151,299
-49,936
| -25% | -$9.53M |
|
61
Pacific Biosciences
PACB
$393M
| $28.9M | 0.41% |
8,363,741
+984,950
| +13% | +$3.4M |
|
62
Teleflex
TFX
$5.59B
| $28.5M | 0.4% |
78,333
| – | – |
|
63
Zimmer Biomet
ZBH
$21B
| $27.2M | 0.38% |
227,508
+122,676
| +117% | +$14.6M |
|
64
Align Technology
ALGN
$10.3B
| $27.1M | 0.38% |
98,869
-104,207
| -51% | -$28.6M |
|
65
Wave Life Sciences
WVE
$1.53B
| $27.1M | 0.38% |
2,602,858
| – | – |
|
66
Q32 Bio
QTTB
$20.9M
| $26.4M | 0.37% |
1,737,122
+125,000
| +8% | +$1.9M |
|
|
HMSY
67
DELISTED
HMS Holdings Corp.
HMSY
| $26.4M | 0.37% |
814,264
+239,087
| +42% | +$7.74M |
|
68
HUTCHMED
HCM
$2.58B
| $26.1M | 0.37% |
947,674
+95,680
| +11% | +$2.64M |
|
69
Thermo Fisher Scientific
TMO
$186B
| $25.2M | 0.36% |
69,491
+29,939
| +76% | +$10.8M |
|
70
Idexx Laboratories
IDXX
$51.8B
| $24.3M | 0.34% |
73,607
+31,696
| +76% | +$10.5M |
|
71
DaVita
DVA
$9.85B
| $23.8M | 0.34% |
+300,200
| New | +$23.8M |
|
|
ABMD
72
DELISTED
Abiomed Inc
ABMD
| $23.4M | 0.33% |
96,699
-11,373
| -11% | -$2.75M |
|
73
Tandem Diabetes Care
TNDM
$845M
| $22.9M | 0.32% |
231,839
+36,801
| +19% | +$3.64M |
|
74
Masimo
MASI
$7.59B
| $22.2M | 0.31% |
97,541
+5,296
| +6% | +$1.21M |
|
75
Kezar Life Sciences
KZR
$28.9M
| $22M | 0.31% |
4,241,940
+723,051
| +21% | +$3.75M |
|